Also trades as: PCLO.V (TSXV) · $vol 0M
PCLOF OTC
PharmaCielo Ltd.
1W: -6.9%
1M: -23.6%
3M: -29.5%
YTD: -44.6%
1Y: +51.1%
3Y: -75.4%
5Y: -96.4%
$0.04
-0.00 (-2.78%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$9M
-53.5% ▼
5Y CAGR: -27.9%
Total Liabilities
$24M
-7.8% ▼
5Y CAGR: +6.1%
Shareholders Equity
-$15M
-104.1% ▼
Cash & Investments
$289K
+95.4% ▲
5Y CAGR: -50.4%
Total Debt
$19M
-9.2% ▼
5Y CAGR: +33.0%
Net Debt
$18M
-10.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5M | $173K | $62K | $148K | $289K |
| Short-Term Investments | $291K | $153K | $0 | $0 | $0 |
| Cash & ST Investments | $6M | $326K | $62K | $148K | $289K |
| Net Receivables | $565K | $714K | $761K | $598K | $619K |
| Inventory | $2M | $2M | $2M | $2M | $2M |
| Other Current Assets | $0 | $692K | $0 | $0 | $0 |
| Total Current Assets | $9M | $4M | $3M | $2M | $4M |
| Property, Plant & Equip. | $26M | $21M | $19M | $16M | $5M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $640K | $473K | $252K | $225K | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $27M | $21M | $19M | $16M | $5M |
| Total Assets | $36M | $25M | $22M | $18M | $9M |
| — Liabilities — | |||||
| Accounts Payable | $8M | $6M | $6M | $5M | $5M |
| Short-Term Debt | $79K | $551K | $16M | $16M | $19M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $112K | $26K | $26K | $142K | $26K |
| Total Current Liabilities | $8M | $7M | $21M | $21M | $24M |
| Long-Term Debt | $7M | $12M | $3M | $5M | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $9M | $12M | $3M | $5M | $0 |
| Total Liabilities | $17M | $19M | $24M | $26M | $24M |
| — Equity — | |||||
| Common Stock | $156M | $162M | $166M | $167M | $168M |
| Retained Earnings | -$168M | -$182M | -$199M | -$208M | -$212M |
| Accumulated OCI | $29M | $27M | $31M | $31M | $29M |
| Total Stockholders Equity | $19M | $6M | -$2M | -$8M | -$15M |
| Total Liabilities & Equity | $36M | $25M | $22M | $18M | $9M |
| — Key Metrics — | |||||
| Total Debt | $8M | $13M | $18M | $21M | $19M |
| Net Debt | $3M | $12M | $18M | $20M | $18M |
| Total Investments | $931K | $626K | $252K | $225K | $0 |